γ134.5 was recognized as a “neurovirulence gene” encoding a protein able to counteract the innate/intrinsic immunity protein kinase R (PKR) response in non-tumor cells [32], and was one of the cornerstones of oHSV design and development (see below). This evidence concerns the gene EIF2AK2 and neoplasm.